A Gleevec, Glivec, CGP-57148B, STI-571, Imatinib Mesylate written confirmation (Gleevec, Glivec, CGP-57148B, STI-571, Imatinib Mesylate WC) is an official document issued by a regulatory agency to a Gleevec, Glivec, CGP-57148B, STI-571, Imatinib Mesylate manufacturer, verifying that the manufacturing facility of a Gleevec, Glivec, CGP-57148B, STI-571, Imatinib Mesylate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Gleevec, Glivec, CGP-57148B, STI-571, Imatinib Mesylate APIs or Gleevec, Glivec, CGP-57148B, STI-571, Imatinib Mesylate finished pharmaceutical products to another nation, regulatory agencies frequently require a Gleevec, Glivec, CGP-57148B, STI-571, Imatinib Mesylate WC (written confirmation) as part of the regulatory process.
click here to find a list of Gleevec, Glivec, CGP-57148B, STI-571, Imatinib Mesylate suppliers with Written Confirmation (WC) on PharmaCompass.